Skip to main navigation
Skip to search
Skip to main content
Ulster University Home
Home
Researchers
Research units
Projects
Research output
Student theses
Datasets
Activities
Press/Media
Prizes
Search by expertise, name or affiliation
Natural Nuclear Factor Kappa Beta Inhibitors: Safe Therapeutic Options for Inflammatory Bowel Disease.
Murtaza Tambuwala
School of Pharm. & Pharmaceut. Sc.
Faculty Of Life & Health Sciences
Research output
:
Contribution to journal
›
Article
›
peer-review
29
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Natural Nuclear Factor Kappa Beta Inhibitors: Safe Therapeutic Options for Inflammatory Bowel Disease.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Abdominal Cancer
14%
Antiinflammatory Agent
14%
Chronic Inflammation
14%
Colorectal Carcinoma
14%
Crohn's Disease
14%
Digestive System Inflammation
14%
Esophagus Cancer
14%
Immunosuppressive Agent
14%
Inflammation
71%
Inflammatory Bowel Disease
100%
Malignant Neoplasm
14%
Nuclear Factor
100%
Side Effect
14%
Ulcerative Colitis
14%
Immunology and Microbiology
Crohn's Disease
14%
Immune System Disorders
14%
Immunosuppressive Drug
14%
Inflammatory Bowel Disease
100%
Innate Immune System
14%
Intestine
14%
Intestine Mucosa
14%
Mediator
14%
Mucosal Immune System
14%
Ulcerative Colitis
14%